Business
Brooks Automation Names Erica McLaughlin to Its Board of Directors
CHELMSFORD, Mass., April 6, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) today announced that Erica McLaughlin has been elected to its Board of
About this update from Azenta, Inc.
[{"type":"text","content":"CHELMSFORD, Mass., April 6, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) today announced that Erica McLaughlin has been elected to its Board of Directors. Ms. McLaughlin, Senior Vice President and CFO of Cabot Corporation, joins the board and the audit committee, bringing deep leadership experience as a global public company CFO and a background in public accounting. \n\"We are excited and honored to have Erica join our Board,\" said Steve Schwartz, President and CEO of Brooks. \"She brings experience as a strong leader in strategy and finance with a large global organization such as Cabot Corporation. Erica will be an invaluable asset to the Board and to Brooks as we continue on our journey of growth and transformation to higher value.\"\nJoseph R. Martin, Chairman of the Brooks Board of Directors, also commented, \"I am delighted to welcome Erica to our Board. She will bring a unique perspective to our Board based on her broad experience and executive leadership roles at Cabot, and she will be a strong contributor to our audit committee.\" \nMs. McLaughlin has been with Cabot Corporation since 2002 in a variety of finance roles of increasing responsibility culminating in her current position as Chief Financial Officer. Prior to Cabot, Ms. McLaughlin worked for KPMG, LLP in their audit services group. She earned an MBA and BS in Accounting from Boston College. She also served on the Board of Directors of the Cabot Boston Credit Union from 2013 through 2016 and currently serves as an executive leader for Cabot's Diversity and Inclusion Steering Committee. \nAbout Brooks AutomationBrooks (Nasdaq: BRKS) is a leading provider of life science sample-based solutions and semiconductor manufacturing solutions worldwide. The Company's Life Sciences business provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. Brooks Life Sciences' GENEWIZ division is a leading provider of DNA gene sequencing and gene synthesis services. With over 40 years as a partner to the semiconductor manufacturing industry, Brooks is a provider of industry-leading precision vacuum robotics, integrated automation systems and contamina...